How Incyte Beat Wall Street Estimates in Q4

Incyte (NASDAQ: INCY) delivered a strong performance in 2019, with its shares soaring 37%. The biotech's momentum has faded so far this year, though.

However, Incyte gave investors a reason to cheer with its fiscal 2019 fourth-quarter and full-year results announced before the market opened on Thursday. Here are the highlights from the company's Q4 update.

Image source: Getty Images.

Continue reading

Source Fool.com